Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
What is Pseudophakia? | OBN
Pseudophakia, is a Latin word, made up of two parts pseudo (fake or artificial) and phakia(lens). It is an incredible visual rehabilitation technique, where an artificial İntraocular lens is introduced into the affected eye after the extraction of a cloudy…
Researchers Unveil Groundbreaking AI System for Eye Care
Researchers from Moorfields Eye Hospital and the UCL Institute of Ophthalmology have achieved a major milestone in artificial intelligence (AI) development. Their groundbreaking AI system, known as RETFound, not only excels in identifying sight-threatening eye diseases but also demonstrates the…
VSY’s ENOVA: Glistening-Free Hydrophobic IOL
VSY Biotechnology launches Enova, the First 100% Glistening Free Hydrophobic Acrylic IOL that does not Require Pre-hydration and Storage in Saline Solution! VSY Biotechnology announces Enova, the first 100% glistening-free hydrophobic acrylic IOL that requires neither pre-hydration nor storage in…
Bausch + Lomb Introduces Dry Eye Drug Miebo in the U.S.
Bausch + Lomb has officially launched Miebo (perfluorohexyloctane ophthalmic solution) for the treatment of dry eye disease (DED) in the United States. Earlier in May, Bausch + Lomb and Novaliq received FDA approval for Miebo, marking it as the first…
FCI Ophthalmics Introduces EzyPor PE Orbital Implant in USI OBN
FCI Ophthalmics announced the launch of EzyPor in the United States. EzyPor is a polyethylene orbital implant with a proprietary suturing platform that is suggested for enucleation, evisceration, and secondary implantation. Ezypor is developed with a smooth anterior suturing surface…
HOYA Surgical Optics Acquires Mid Labs and Fritz Ruck
HOYA Surgical Optics (“HSO”), the intraocular lens and related products division of HOYA Group, today announced that it has completed the acquisition of medical device companies Mid Labs and Fritz Ruck. Mid Labs is a California-based company focused on the…
Alcon Introduces Launch Of AcrySof IQ Vivity
Development of active glasses for mitigating presbyopia has become an active area of research, facilitated by the miniaturization of focus-tunable lenses as well as the increased processing power of modern computers. Alcon the global leader in eye care dedicated to…
Ophthalmic Market Projected to Reach $532.8M by 2026
The global ophthalmic sutures market size is expected to reach USD 532.8 million by 2026, expanding at a CAGR of 6.4% over the forecast period, according to a new report by Grand View research, Inc. Key factors driving the market…
Cataract Journey and Medical Staff’s Role in Patient Care
Cataract surgery is the most frequently performed operative procedure worldwide, typically concludes with the implantation of an artificial intraocular lens (IOL) to correct aphakia (absence of the crystalline lens). The surgery—which involves removing the eye’s clouded lens and replacing it…
YAG Laser Capsulotomy Procedure | OBN
Cataract surgery has revolutionized the way we restore vision, but what happens when clarity begins to fade post-surgery? This is where YAG laser capsulotomy steps in, offering a solution that restores vision and rejuvenates the eyes. In this article, we’ll…